OKYO Ebitda vs Interest Expense Analysis

OKYO Stock  USD 1.01  0.00  0.00%   
OKYO Pharma financial indicator trend analysis is much more than just breaking down OKYO Pharma prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether OKYO Pharma is a good investment. Please check the relationship between OKYO Pharma Ebitda and its Interest Expense accounts. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in OKYO Pharma Ltd. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing.

Ebitda vs Interest Expense

Ebitda vs Interest Expense Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of OKYO Pharma Ebitda account and Interest Expense. At this time, the significance of the direction appears to have no relationship.
The correlation between OKYO Pharma's Ebitda and Interest Expense is 0.02. Overlapping area represents the amount of variation of Ebitda that can explain the historical movement of Interest Expense in the same time period over historical financial statements of OKYO Pharma Ltd, assuming nothing else is changed. The correlation between historical values of OKYO Pharma's Ebitda and Interest Expense is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Ebitda of OKYO Pharma Ltd are associated (or correlated) with its Interest Expense. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Interest Expense has no effect on the direction of Ebitda i.e., OKYO Pharma's Ebitda and Interest Expense go up and down completely randomly.

Correlation Coefficient

0.02
Relationship DirectionPositive 
Relationship StrengthInsignificant

Ebitda

Interest Expense

The cost incurred by an entity for borrowed funds, including loans, bonds, or lines of credit.
Most indicators from OKYO Pharma's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into OKYO Pharma current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in OKYO Pharma Ltd. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing.
At this time, OKYO Pharma's Selling General Administrative is very stable compared to the past year. As of the 5th of December 2024, Tax Provision is likely to grow to about 23.5 K, while Issuance Of Capital Stock is likely to drop about 3.2 M.
 2021 2022 2023 2024 (projected)
Cost Of Revenue2.4K3.8K7.5K6.1K
Research Development1.6M6.3M8.2K7.8K

OKYO Pharma fundamental ratios Correlations

-0.510.990.85-0.80.71-0.470.790.960.8-0.18-0.1-0.130.38-0.510.80.130.59-0.490.73-0.410.79-0.180.110.2-0.58
-0.51-0.61-0.50.44-0.780.86-0.4-0.5-0.44-0.53-0.390.14-0.241.0-0.39-0.15-0.160.96-0.290.63-0.430.710.25-0.680.85
0.99-0.610.85-0.80.76-0.550.790.960.8-0.09-0.04-0.140.38-0.610.790.140.57-0.590.71-0.470.79-0.270.070.28-0.65
0.85-0.50.85-0.470.57-0.440.460.910.58-0.12-0.22-0.290.22-0.50.570.110.25-0.510.36-0.370.59-0.180.040.14-0.57
-0.80.44-0.8-0.47-0.780.42-1.0-0.62-0.870.220.020.03-0.380.44-0.86-0.51-0.390.4-0.940.43-0.80.16-0.22-0.270.44
0.71-0.780.760.57-0.78-0.680.760.610.79-0.050.12-0.270.31-0.780.740.520.18-0.770.7-0.660.71-0.66-0.170.38-0.84
-0.470.86-0.55-0.440.42-0.68-0.42-0.43-0.45-0.49-0.320.06-0.170.86-0.42-0.12-0.140.71-0.220.35-0.370.530.1-0.880.68
0.79-0.40.790.46-1.00.76-0.420.610.87-0.25-0.04-0.020.38-0.40.860.510.39-0.350.93-0.370.8-0.120.240.28-0.41
0.96-0.50.960.91-0.620.61-0.430.610.68-0.13-0.13-0.190.33-0.50.67-0.040.6-0.510.55-0.40.7-0.20.040.15-0.6
0.8-0.440.80.58-0.870.79-0.450.870.68-0.21-0.03-0.10.26-0.440.990.430.31-0.40.77-0.410.65-0.230.220.28-0.47
-0.18-0.53-0.09-0.120.22-0.05-0.49-0.25-0.13-0.210.650.46-0.03-0.52-0.21-0.290.0-0.46-0.350.02-0.24-0.2-0.070.7-0.11
-0.1-0.39-0.04-0.220.020.12-0.32-0.04-0.13-0.030.650.68-0.09-0.39-0.03-0.110.08-0.36-0.060.09-0.09-0.13-0.080.46-0.08
-0.130.14-0.14-0.290.03-0.270.06-0.02-0.19-0.10.460.68-0.080.14-0.03-0.130.10.19-0.040.63-0.110.480.260.240.49
0.38-0.240.380.22-0.380.31-0.170.380.330.26-0.03-0.09-0.08-0.240.270.070.36-0.270.45-0.10.21-0.2-0.330.04-0.35
-0.511.0-0.61-0.50.44-0.780.86-0.4-0.5-0.44-0.52-0.390.14-0.24-0.4-0.15-0.170.96-0.290.63-0.430.710.25-0.680.85
0.8-0.390.790.57-0.860.74-0.420.860.670.99-0.21-0.03-0.030.27-0.40.420.32-0.350.77-0.320.65-0.140.230.27-0.41
0.13-0.150.140.11-0.510.52-0.120.51-0.040.43-0.29-0.11-0.130.07-0.150.42-0.49-0.160.52-0.220.36-0.19-0.040.05-0.22
0.59-0.160.570.25-0.390.18-0.140.390.60.310.00.080.10.36-0.170.32-0.49-0.170.46-0.180.37-0.070.00.05-0.25
-0.490.96-0.59-0.510.4-0.770.71-0.35-0.51-0.4-0.46-0.360.19-0.270.96-0.35-0.16-0.17-0.310.7-0.440.750.35-0.480.88
0.73-0.290.710.36-0.940.7-0.220.930.550.77-0.35-0.06-0.040.45-0.290.770.520.46-0.31-0.370.75-0.180.010.04-0.42
-0.410.63-0.47-0.370.43-0.660.35-0.37-0.4-0.410.020.090.63-0.10.63-0.32-0.22-0.180.7-0.37-0.420.720.11-0.130.77
0.79-0.430.790.59-0.80.71-0.370.80.70.65-0.24-0.09-0.110.21-0.430.650.360.37-0.440.75-0.42-0.20.030.13-0.51
-0.180.71-0.27-0.180.16-0.660.53-0.12-0.2-0.23-0.2-0.130.48-0.20.71-0.14-0.19-0.070.75-0.180.72-0.20.55-0.270.86
0.110.250.070.04-0.22-0.170.10.240.040.22-0.07-0.080.26-0.330.250.23-0.040.00.350.010.110.030.550.160.49
0.2-0.680.280.14-0.270.38-0.880.280.150.280.70.460.240.04-0.680.270.050.05-0.480.04-0.130.13-0.270.16-0.33
-0.580.85-0.65-0.570.44-0.840.68-0.41-0.6-0.47-0.11-0.080.49-0.350.85-0.41-0.22-0.250.88-0.420.77-0.510.860.49-0.33
Click cells to compare fundamentals

OKYO Pharma Account Relationship Matchups

OKYO Pharma fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets597.4K7.1M4.3M5.2M1.5M1.5M
Total Current Liabilities710.7K1.7M1.4M7.3M7.4M7.8M
Total Stockholder Equity(139.8K)5.3M2.9M(2.1M)(5.9M)(5.6M)
Property Plant And Equipment Net30.7K104.6K5.2K7.2K3.4K3.2K
Net Debt(203.3K)(6.8M)(2.7M)(1.8M)(826.8K)(868.2K)
Retained Earnings(85.9M)(106.0M)(112.4M)(125.7M)(142.5M)(135.4M)
Accounts Payable593.7K211.0K517.7K1.0M4.4M4.6M
Cash235.0K6.9M2.7M4.0M826.8K785.5K
Non Current Assets Total30.7K104.6K5.2K7.2K3.4K3.2K
Cash And Short Term Investments235.0K6.9M2.7M4.0M826.8K785.5K
Common Stock Shares Outstanding595.5M672.8M979.2M22.3M29.3M27.9M
Liabilities And Stockholders Equity597.4K7.1M4.3M5.2M1.5M1.5M
Other Current Assets6.4K97.4K711.2K171.2K130.1K111.8K
Other Stockholder Equity83.5M(306.0K)2.4M3.7M4.8M4.6M
Total Liab737.2K1.8M1.4M7.3M7.4M7.8M
Total Current Assets566.7K7.0M4.3M5.2M1.5M1.5M
Other Current Liab111.9K1.5M835.5K4.4M3.0M3.2M
Net Receivables326.2K76.3K883.4K980.1K580.9K347.0K
Accumulated Other Comprehensive Income2.2M12.8M(11.0M)(11.5M)(11.3M)(10.7M)
Common Stock67.5M111.6M124.0M131.4M143.1M110.9M
Net Tangible Assets255.4K(113.0K)3.9M2.2M2.6M1.8M
Net Invested Capital(113.0K)3.9M2.9M161.9K(5.9M)(5.6M)
Capital Stock67.5M111.6M124.0M131.4M143.1M118.4M
Net Working Capital(116.4K)3.8M2.9M(2.1M)(5.9M)(5.6M)

Pair Trading with OKYO Pharma

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if OKYO Pharma position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in OKYO Pharma will appreciate offsetting losses from the drop in the long position's value.

Moving against OKYO Stock

  0.4A Agilent TechnologiesPairCorr
  0.4DOMH Dominari HoldingsPairCorr
The ability to find closely correlated positions to OKYO Pharma could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace OKYO Pharma when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back OKYO Pharma - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling OKYO Pharma Ltd to buy it.
The correlation of OKYO Pharma is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as OKYO Pharma moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if OKYO Pharma moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for OKYO Pharma can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether OKYO Pharma offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of OKYO Pharma's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Okyo Pharma Ltd Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Okyo Pharma Ltd Stock:
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in OKYO Pharma Ltd. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing.
You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of OKYO Pharma. If investors know OKYO will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about OKYO Pharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.57)
Return On Assets
(2.92)
Return On Equity
(29.69)
The market value of OKYO Pharma is measured differently than its book value, which is the value of OKYO that is recorded on the company's balance sheet. Investors also form their own opinion of OKYO Pharma's value that differs from its market value or its book value, called intrinsic value, which is OKYO Pharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because OKYO Pharma's market value can be influenced by many factors that don't directly affect OKYO Pharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between OKYO Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if OKYO Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, OKYO Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.